Published in Brain Res on March 23, 1998
Intraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model. Neurotherapeutics (2009) 0.93
Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. Br J Pharmacol (2000) 0.84
Effects of the mGluR2/3 agonist LY379268 and the mGluR5 antagonist MPEP on handling-induced convulsions during ethanol withdrawal in mice. Alcohol (2008) 0.81
Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats. Brain Res (2008) 0.81
Activation of group 2 metabotropic glutamate receptors reduces behavioral and electrographic correlates of pilocarpine induced status epilepticus. Epilepsy Res (2013) 0.79
Developmental regulation of hippocampal excitatory synaptic transmission by metabotropic glutamate receptors. Br J Pharmacol (2000) 0.78
Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents? Curr Neuropharmacol (2005) 0.77
Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis. Curr Neuropharmacol (2016) 0.75
Involvement of group II metabotropic glutamate receptors in stress-induced behavioural sensitization. Psychopharmacology (Berl) (2007) 0.75
Respiration in vitro of synaptosomes from mammalian cerebral cortex. J Neurochem (1969) 2.08
The inhibitory effect of sodium n-dipropyl acetate on the degradative enzymes of the GABA shunt. FEBS Lett (1975) 1.44
Anticonvulsant action of excitatory amino acid antagonists. Science (1982) 1.29
Metabolism of glucose and glutamate by synaptosomes from mammalian cerebral cortex. J Neurochem (1969) 1.24
Ionic basis for the depolarization of cerebral tissues by excitatory acidic amino acids. J Neurochem (1966) 1.16
Glutamine--a major substrate for nerve endings. J Neurochem (1978) 1.16
Metabolic response of synaptosomes to electrical stimulation: release of amino acids. Brain Res (1970) 1.13
The metabolism of glucose 6-phosphate by mammalian cerebral cortex in vitro. Biochem J (1971) 1.09
Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals. Brain Res (1978) 1.07
Glutamine and glucose as precursors of transmitter amino acids: ex vivo studies. J Neurochem (1983) 1.07
Metabolism of beds of mammalian cortical synaptosomes: response to depolarizing influences. J Neurochem (1972) 1.06
Specific release of endogenous glutamate from piriform cortex stimulated in vitro. Brain Res (1976) 1.06
In vivo release from cerebral cortex of [14C]glutamate synthesized from [U-14C]glutamine. J Neurochem (1983) 1.00
Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J Neurochem (1992) 1.00
Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung (1984) 0.98
Stimulated incorporation of amino acids into proteins of synaptosomal fractions induced by depolarizing treatments. J Neurochem (1977) 0.96
Depolarizing stimuli and the release of physiologically active amino acids from suspensions of mammalian synaptosomes. J Neurochem (1973) 0.93
Constituents of a microsomal fraction from the mammalian brain: their solubilization, especially by detergents. Biochem J (1964) 0.92
Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci Lett (1983) 0.92
Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration. Eur J Pharmacol (1983) 0.90
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease. Eur J Neurosci (2005) 0.90
Tetanus toxin inhibits amino acid release from nerve endings in vitro. Nat New Biol (1973) 0.90
The stimulus-induced release of acetylcholine from synaptosome beds and its calcium dependence. J Neurochem (1972) 0.89
Actions of tremorgenic fungal toxins on neurotransmitter release. J Neurochem (1980) 0.87
Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro. Neuropharmacology (2000) 0.86
Patterns of amino acid release from nerve-endings isolated from spinal cord and medulla. J Neurochem (1973) 0.85
Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV). Brain Res (1998) 0.85
Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure. J Ethnopharmacol (1988) 0.84
On glutaminase activity in mammalian synaptosomes. Brain Res (1976) 0.84
On the site of origin of transmitter amino acids released by depolarization of nerve terminals in vitro. J Neurochem (1977) 0.84
The action of gamma-vinyl-GABA and gamma-acetylenic-GABA on the resting and stimulated release of GABA in vivo. Brain Res (1980) 0.84
Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur J Pharmacol (1988) 0.83
The distribution of cation-stimulated adenosine triphosphatase in subcellular fractions from bovine cerebral cortex. J Neurochem (1966) 0.83
A comparison of the anticonvulsant potency of (+/-) 2-amino-5-phosphonopentanoic acid and (+/-) 2-amino-7-phosphonoheptanoic acid. Neuroscience (1983) 0.83
Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence. Neuropharmacology (2001) 0.83
Brain-derived neurotrophic factor in human platelets. Biochem Pharmacol (1997) 0.83
Effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in vivo and in vitro studies. J Neurochem (1995) 0.82
Glucose and amino acid metabolism in some invertebrate nervous systems. J Neurochem (1969) 0.82
Participation of intracellular sites in the action of Ca2+ channel blockers. Eur J Pharmacol (1986) 0.82
The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. Brain Res Dev Brain Res (1996) 0.82
Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J Neurochem (1980) 0.82
Evidence for a role of presynaptic AMPA receptors in the control of neuronal glutamate release in the rat forebrain. Eur J Pharmacol (1997) 0.81
Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Res (1997) 0.81
Excitatory amino acid receptors and depolarization-induced Ca2+ influx into hippocampal slices. J Neurochem (1987) 0.81
Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor. Brain Res Dev Brain Res (2001) 0.81
Enhancement of depolarization-induced synaptosomal calcium uptake and neurotransmitter release by Bay K8644. Biochem Pharmacol (1986) 0.81
Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br J Pharmacol (1986) 0.81
Relative activities of glutamine synthetase and glutaminase in mammalian synaptosomes. J Neurochem (1979) 0.81
The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro. Brain Res Dev Brain Res (1994) 0.81
Evidence for presynaptic cholinergic receptors on dopaminergic terminals: degeneration studies with 6-hydroxydopamine. Neurosci Lett (1979) 0.81
Effects of gamma-acetylenic GABA and gamma-vinyl GABA on synaptosomal release and uptake of GABA. Biochem Pharmacol (1981) 0.81
Actions of a tremorgenic mycotoxin on amino acid transmitter release in vivo. Biochem Pharmacol (1982) 0.81
The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Brain Res (1994) 0.81
On the specificity of verapamil as a calcium channel-blocker. Biochem Pharmacol (1985) 0.81
Comparison of human recombinant adenosine A2B receptor function assessed by Fluo-3-AM fluorometry and microphysiometry. Br J Pharmacol (2003) 0.80
Studies on cigarette smoke induced oxidative DNA damage and reduced spermatogenesis in rats. J Environ Biol (2014) 0.80
Depolarisation-induced changes in muscarinic cholinergic receptors in synaptosomes. Nature (1979) 0.80
Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochem Res (1992) 0.80
Compartmentation of synaptosomal dopamine. Adv Biochem Psychopharmacol (1978) 0.80
Co-release of acetylcholine, glutamate and taurine from synaptosomes of Torpedo electric organ. Neurosci Lett (1987) 0.80
The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture. Neuroreport (2000) 0.80
Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes. Biochem Pharmacol (1981) 0.80
Striatal extracts promote the survival and phenotypic expression of rat fetal dopaminergic neurons in vitro. Neurosci Lett (2000) 0.80
Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice. Biochem Pharmacol (1984) 0.79
Effects of anticonvulsants on the in vivo and in vitro release of GABA. Biochem Pharmacol (1981) 0.79
Common anticonvulsants inhibit Ca2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia (1987) 0.79
Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res (1995) 0.79
Dopamine inhibition of the release of endogenous acetylcholine from corpus striatum and cerebral cortex in tissue slices and synaptosomes: a presynaptic response? J Neurochem (1982) 0.79
Actions of Ptychodiscus brevis red tide toxin on metabolic and transmitter-releasing properties of synaptosomes. J Neurochem (1982) 0.79
Suppression of audiogenic seizures in DBA/2 mice by two new dipeptide NMDA receptor antagonists. Neurosci Lett (1984) 0.79
Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling. Eur J Pharmacol (1995) 0.79
N-methyl-D-aspartate releases gamma-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. J Neurochem (1993) 0.79
The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists. Brain Res (1983) 0.79
Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: applications in cell replacement treatment for Parkinson's disease. Prog Neurobiol (2005) 0.79
N-methyl-D-aspartate releases excitatory amino acids in rat corpus striatum in vivo. J Neurochem (1991) 0.78
The depolarisation-induced release of [125I]BDNF from brain tissue. Brain Res (1996) 0.78
Convulsions and activation of epileptic foci induced by monosodium glutamate and related compounds. Biochem Pharmacol (1977) 0.78
Effect of alpha-amino-4-phosphonobutyrate on the release of endogenous glutamate and aspartate from cortical synaptosomes of epileptic rats. J Neurochem (1985) 0.78
Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study. Neuroscience (2001) 0.78
Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J Neurochem (1988) 0.78
The effects of focal N-methyl-D-aspartate pretreatment on the parameters of amygdaloid electrical kindling. Eur J Pharmacol (1997) 0.78
Inhibition of depolarization-coupled calcium fluxes and transmitter release in vitro by morphine. FEBS Lett (1982) 0.78
Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants. Brain Res Dev Brain Res (1997) 0.78
Nerve growth factors and the control of neurotransmitter phenotype selection in the mammalian central nervous system. Prog Neurobiol (1997) 0.78
Anticonvulsant and proconvulsant properties of a series of structural isomers of piperidine dicarboxylic acid. Neuropharmacology (1984) 0.78
Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. Biochem Pharmacol (1986) 0.77
Absence of an effect of histamine, noradrenaline and depolarizing agents on the levels of adenosine 3', 5'-monophosphate in nerve endings isolated from cerebral cortex. Biochem Pharmacol (1974) 0.77
The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. Eur J Pharmacol (1997) 0.77
Lack of effect of focally administered prostaglandins on electrically kindled seizure activity. Prostaglandins (1991) 0.77
Metabolic and secretory processes in nerve-endings isolated from post-mortem brain. Neurosci Lett (1979) 0.77
Effect of beta-bungarotoxin on the release of endogenous amino aids from the sensorimotor cortex. J Neurochem (1981) 0.77